223519-11-7 Usage
Uses
Used in Pharmaceutical Industry:
5-AMINO-3-BROMO-4-METHYL-1-CARBOXYLIC ACID METHYL ESTER is used as an intermediate in the synthesis of various pharmaceuticals for its ability to participate in chemical reactions such as esterification, amidation, and nucleophilic substitutions. Its reactivity and structural properties contribute to the development of diverse organic compounds with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 5-AMINO-3-BROMO-4-METHYL-1-CARBOXYLIC ACID METHYL ESTER serves as a key intermediate in the production of various agrochemicals. Its reactive nature allows for the synthesis of compounds with pesticidal, herbicidal, or other agricultural applications, enhancing crop protection and yield.
Used in Organic Synthesis:
5-AMINO-3-BROMO-4-METHYL-1-CARBOXYLIC ACID METHYL ESTER is utilized as a building block in organic synthesis for the creation of complex molecules. Its structural properties and reactivity make it suitable for the formation of a wide range of organic compounds, contributing to advancements in the chemical industry and the development of new materials and products.
Check Digit Verification of cas no
The CAS Registry Mumber 223519-11-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,3,5,1 and 9 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 223519-11:
(8*2)+(7*2)+(6*3)+(5*5)+(4*1)+(3*9)+(2*1)+(1*1)=107
107 % 10 = 7
So 223519-11-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H10BrNO2/c1-5-7(10)3-6(4-8(5)11)9(12)13-2/h3-4H,11H2,1-2H3
223519-11-7Relevant articles and documents
SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE
-
, (2019/01/21)
The present invention provides compounds of Formula (I) or a subgeneric structure or species thereof, or a pharmaceutically acceptable salt, ester, solvate, and/or prodrug thereof, and methods and compositions for treating or ameliorating abnormal cell pr
CARBOXY SUBSTITUTED (HETERO) AROMATIC RING DERIVATIVES AND PREPARATION METHOD AND USES THEREOF
-
, (2017/03/21)
Carboxy-substituted (hetero)aryl derivatives, pharmaceutical compositions comprising these compounds, and methods of preparing such compounds and compositions are provided. The compounds or compositions are useful in inhibiting xanthine oxidase and urate anion transporter 1, and also can be used in the treatment or prevention of diseases associated with high blood uric acid level in mammals, especially humans.
Synthesis of substituted 4-(1H-indol-6-yl)-1H-indazoles as potential PDK1 inhibitors
Brzozowski, Martin,O'Brien, Nathan J.,Wilson, David J.D.,Abbott, Belinda M.
, p. 318 - 326 (2014/01/06)
The development of a preparative route to a series of novel 4-(1H-indol-6-yl)-1H-indazole compounds as potential PDK1 inhibitors is described. The synthetic strategy centres on the late-stage Suzuki cross-coupling of N-unprotected indazole and indole frag
